Malvika Verma

731 total citations · 1 hit paper
4 papers, 443 citations indexed

About

Malvika Verma is a scholar working on Molecular Biology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Malvika Verma has authored 4 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 1 paper in Infectious Diseases and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Malvika Verma's work include Hepatitis B Virus Studies (1 paper), Biomedical Ethics and Regulation (1 paper) and Hepatitis C virus research (1 paper). Malvika Verma is often cited by papers focused on Hepatitis B Virus Studies (1 paper), Biomedical Ethics and Regulation (1 paper) and Hepatitis C virus research (1 paper). Malvika Verma collaborates with scholars based in United States, Australia and Canada. Malvika Verma's co-authors include Giovanni Traverso, Róbert Langer, Paramesh Karandikar, Ameya R. Kirtane, Jennifer Furin, İmran Özer, Alexandra Teixeira, Ryan Gallagher, Michael Choy and Wen Xie and has published in prestigious journals such as Nature Nanotechnology, Nature Reviews Drug Discovery and Clinical Infectious Diseases.

In The Last Decade

Malvika Verma

4 papers receiving 439 citations

Hit Papers

Nanotechnology approaches for global infectious diseases 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nanotechnology approaches for global infectious diseases
    2021 328 citations Ameya R. Kirtane, Malvika Verma et al. Nature Nanotechnology profile →

Peers

Malvika Verma
Melahat Bağırova Türkiye
Mohsen Mehrabi Iran
Nancy J. Millenbaugh United States
Priyanka Prabhu India
Paramesh Karandikar United States
Upendra P. Lambe India
Ali Akbar Pourfatollah Iran
Jasmin Federizon United States
Mônica Pereira Garcia Brazil
Mateusz Cieśluk Poland
Melahat Bağırova Türkiye
Malvika Verma
Citations per year, relative to Malvika Verma Malvika Verma (= 1×) peers Melahat Bağırova

Countries citing papers authored by Malvika Verma

Since Specialization
Citations

This map shows the geographic impact of Malvika Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malvika Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malvika Verma more than expected).

Fields of papers citing papers by Malvika Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malvika Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malvika Verma. The network helps show where Malvika Verma may publish in the future.

Co-authorship network of co-authors of Malvika Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Malvika Verma. A scholar is included among the top collaborators of Malvika Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malvika Verma. Malvika Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Verma, Malvika, et al.. (2023). The next-generation CAR-T therapy landscape. Nature Reviews Drug Discovery. 22(10). 776–777. 38 indexed citations
2.
Verma, Malvika, İmran Özer, Wen Xie, et al.. (2023). The landscape for lipid-nanoparticle-based genomic medicines. Nature Reviews Drug Discovery. 22(5). 349–350. 69 indexed citations
3.
Kirtane, Ameya R., Malvika Verma, Paramesh Karandikar, et al.. (2021). Nanotechnology approaches for global infectious diseases. Nature Nanotechnology. 16(4). 369–384. 328 indexed citations breakdown →
4.
Astemborski, Jacqueline, Gregory D. Kirk, Mark Sulkowski, et al.. (2021). Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments. Clinical Infectious Diseases. 75(1). 3–10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melahat Bağırova Breakdown of academic impact, for papers by Mohsen Mehrabi Breakdown of academic impact, for papers by Nancy J. Millenbaugh Breakdown of academic impact, for papers by Priyanka Prabhu Breakdown of academic impact, for papers by Paramesh Karandikar Breakdown of academic impact, for papers by Upendra P. Lambe Breakdown of academic impact, for papers by Ali Akbar Pourfatollah Breakdown of academic impact, for papers by Jasmin Federizon Breakdown of academic impact, for papers by Mônica Pereira Garcia Breakdown of academic impact, for papers by Mateusz Cieśluk
Rankless by CCL
2026